Figure 2.

Prevalence estimates of resistance per antimicrobial, at the horse level (A), and at the premises level (B), in a cross‐sectional study of 132 healthy adult horses, in 38 premises, performed in 2015, in France. AMC, amoxicillin‐Clavulanic acid; AMP, ampicillin; AZY, azithromycin; CHL, chloramphenicol; CIP, ciprofloxacin; CRO, ceftriaxone; FOX, Cefoxitin; GEN, gentamicin; NA, Nalidixic acid; SSS, Sulfisoxazole; STR, streptomycin; TET, tetracycline; TMS, trimethoprim‐sulfamethoxazole; XNL, Ceftiofur. Bars represent 95% confidence intervals. We tested 348 isolates in total